New incident report
Incident Report Number: 2017-7209
Registrant Reference Number: 5800820
Registrant Name (Full Legal Name no abbreviations): Sure-Gro IP Inc.
Address: 1900 Minnesota Crt
City: Mississauga
Prov / State: Ontario
Country: Canada
Postal Code: L5N 3C9
Domestic Animal
Country: CANADA
Prov / State: ONTARIO
PMRA Registration No. 31794 PMRA Submission No. EPA Registration No.
Product Name: Wilson Ultra total WipeOut Ready To Use
Yes
Unknown
Site: Res. - Out Home / Rés - à l'ext.maison
Unknown
Other
Dog / Chien
unknown
1
Female
0.5
8
lbs
Unknown
Unknown / Inconnu
>24 hrs <=3 days / >24 h <=3 jours
System
Unknown / Inconnu
Yes
No
Unknown/Inconnu
Accidental ingestion/Ingestion accident.
(eg. description of the frequency and severity of the symptoms
He caller sprayed the product in his yard a couple of days ago. His neighbors dog developed an upset stomach and shaking yesterday. The neighbor believes this is due to the herbicide. TOE: 2 days ago. The animal has not been in his yard. Dog has been taken to the vet. R: active is Ammonium Nonanoate and it is an irritant. SX do not appear related unless the animal got into the yard and ingested weeds from the sprayed area. Caller given case number. Call back with questions/concerns. On 05/16/17, Per email received, cb to pet Owner. Neighbor's dog is still sick and blaming this caller. There is no change in hx or sxs. Assured caller this is an irritant, but concern could be for other pesticides like pyrethrins that can cause said sxs in canines. Caller has case # and will share with pet owner if she addresses the concern again. MSDS can be faxed to the owner's DVM.
Minor
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified.